Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Business Insights | R&D Cost Cutting: Managing cost containment and safeguarding productivity

R&D Cost Cutting: Managing cost containment and safeguarding productivity

In recent years, drug developers have been under significant pressure to introduce new products while confronting escalating R&D costs, blockbuster patent expirations and heightened regulatory scrutiny. The current global economic climate has now intensified this pressure, creating new imperatives for manufacturers to cut costs. However, selecting and successfully implementing the most appropriate cost-cutting initiative is critical to avoid jeopardizing future productivity. ‘R&D Cost Cutting: Managing cost containment and safeguarding productivity’ is a new report published by Business Insights that provides in-depth analysis of the benefits and risks surrounding leading R&D cost cutting strategies. This report analyses changes to drug development imperatives caused by increased financial restrictions, and uses detailed case studies to assess leading cost reducing approaches such as internal refocusing, outsourcing/offshoring and drug development alliances. The potential of industry-wide ‘information sharing’ initiatives are also assessed. This report also compares the relative success of major companies’ cost containment measures and forecasts how such initiatives will develop over the next five years.

Published: April 2009 - Global.

Table of Contents
Price: $3,825.00 / €2,556.63

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions